134 related articles for article (PubMed ID: 28344605)
21. Evaluation of an active magnetic resonance tracking system for interstitial brachytherapy.
Wang W; Viswanathan AN; Damato AL; Chen Y; Tse Z; Pan L; Tokuda J; Seethamraju RT; Dumoulin CL; Schmidt EJ; Cormack RA
Med Phys; 2015 Dec; 42(12):7114-21. PubMed ID: 26632065
[TBL] [Abstract][Full Text] [Related]
22. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
Dimopoulos JC; Kirisits C; Petric P; Georg P; Lang S; Berger D; Pötter R
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):83-90. PubMed ID: 16839702
[TBL] [Abstract][Full Text] [Related]
23. The Montreal split ring applicator: Towards highly adaptive gynecological brachytherapy using 3D-printed biocompatible patient-specific interstitial caps.
Kamio Y; Roy MÈ; Morgan LA; Barkati M; Beauchemin MC; DeBlois F; Basaric B; Carrier JF; Bedwani S
J Contemp Brachytherapy; 2023 Dec; 15(6):453-464. PubMed ID: 38230395
[TBL] [Abstract][Full Text] [Related]
24. MRI-driven design of customised 3D printed gynaecological brachytherapy applicators with curved needle channels.
Laan RC; Nout RA; Dankelman J; van de Berg NJ
3D Print Med; 2019 May; 5(1):8. PubMed ID: 31098743
[TBL] [Abstract][Full Text] [Related]
25. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome.
Mahantshetty U; Sturdza A; Naga Ch P; Berger D; Fortin I; Motisi L; Schmid MP; Aravindakshan D; Ghadi Y; Swamidas JV; Chopra S; Gurram L; Nesvacil N; Kirisits C; Pötter R
Radiother Oncol; 2019 Dec; 141():123-129. PubMed ID: 31495516
[TBL] [Abstract][Full Text] [Related]
26. PET-guided three-dimensional treatment planning of intracavitary gynecologic implants.
Mutic S; Grigsby PW; Low DA; Dempsey JF; Harms WB; Laforest R; Bosch WR; Miller TR
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1104-10. PubMed ID: 11958908
[TBL] [Abstract][Full Text] [Related]
27. Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer.
Yoshida K; Yamazaki H; Nose T; Shiomi H; Yoshida M; Mikami M; Takenaka T; Kotsuma T; Tanaka E; Kuriyama K; Harada Y; Tohda A; Yasunaga Y; Oka T
Brachytherapy; 2010; 9(1):36-41. PubMed ID: 19736046
[TBL] [Abstract][Full Text] [Related]
28. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
[TBL] [Abstract][Full Text] [Related]
29. The use of trans-applicator intracavitary ultrasonography in brachytherapy for cervical cancer: phantom study of a novel approach to 3D image-guided brachytherapy.
Tamaki T; Miyaura K; Murakami T; Kumazaki Y; Suzuki Y; Nakano T; Kato S
J Contemp Brachytherapy; 2017 Apr; 9(2):151-157. PubMed ID: 28533804
[TBL] [Abstract][Full Text] [Related]
30. SU-E-T-425: Impact of Model Based Dose Calculation Algorithm for Ir-192 Intracavitary Brachytherapy with Shielded Applicator.
Mikell J; Klopp A; Price M; Mourtada F
Med Phys; 2012 Jun; 39(6Part16):3802. PubMed ID: 28517225
[TBL] [Abstract][Full Text] [Related]
31. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component.
Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC
Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917
[TBL] [Abstract][Full Text] [Related]
32. A novel method for vaginal cylinder treatment planning: a seamless transition to 3D brachytherapy.
Malhotra HK; Wu V; Wang Z; Patil S
J Contemp Brachytherapy; 2012 Jun; 4(2):92-100. PubMed ID: 23349650
[TBL] [Abstract][Full Text] [Related]
33. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
Fredman E; Traughber B; Podder T; Colussi V; Zheng Y; Russo S; Herrmann K; Paspulati R; Waggoner S; Zanotti K; Nagel C; Nakayama J; Machtay M; Ellis R
Brachytherapy; 2018; 17(2):334-344. PubMed ID: 29097137
[TBL] [Abstract][Full Text] [Related]
34. A real-time applicator position monitoring system for gynecologic intracavitary brachytherapy.
Xia J; Waldron T; Kim Y
Med Phys; 2014 Jan; 41(1):011703. PubMed ID: 24387495
[TBL] [Abstract][Full Text] [Related]
35. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
[TBL] [Abstract][Full Text] [Related]
36. Can an in-person hands-on applicator-based teaching session improve trainee knowledge and comfort with complex gynecologic brachytherapy?
Groszkiewicz A; Foust E; Palestra B; Ertel MC; Boisen M; Sukumvanich P; Smith SK; Smith RP; Vargo JA
Brachytherapy; 2024; 23(3):290-300. PubMed ID: 38519351
[TBL] [Abstract][Full Text] [Related]
37. In vivo dosimetry in gynecological applications-A feasibility study.
Van Gellekom MPR; Canters RAM; Dankers FJWM; Loopstra A; van der Steen-Banasik EM; Haverkort MAD
Brachytherapy; 2018; 17(1):146-153. PubMed ID: 28528720
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric comparison of ring and ovoid applicators.
Tuncell N; Toy A; Demiral AN; Cetingoz R; Garipagaoglu M
J BUON; 2009; 14(3):451-5. PubMed ID: 19810138
[TBL] [Abstract][Full Text] [Related]
39. Place of modern imaging in brachytherapy planning.
Hellebust TP
Cancer Radiother; 2018 Jun; 22(4):326-333. PubMed ID: 29858136
[TBL] [Abstract][Full Text] [Related]
40. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA
Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
